Meballymalum
Meballymalum Brand names, Meballymalum Analogs
- (+/-)-Secobarbital
- Barbosec
- Bipanal
- Bipinal sodium
- DEA No. 2315
- DEA No. 2316
- Evronal
- Evronal Sodium
- Evrronal
- Hypotrol
- Hyptran
- Imesonal
- Immenoctal
- Immenox
- Meballymal
- Meballymal sodium
- Meballymalum
- Novosecobarb
- Pramil
- Quinalbarbital
- Quinalbarbitone
- Quinalbarbitone sodium
- Quinalspan
- Sebar
- Seco 8
- Secobarbital (USP)
- Secobarbital Sodium
- Secobarbital [USAN:INN]
- Secobarbital suppository dosage form
- Secobarbitale [DCIT]
- Secobarbitalum [INN-Latin]
- Secobarbitone
- Seconal
- Seconal (TN)
- Seconal Sodium
- Sedutain
- Seotal
- Sodium Secobarbital
- Sodium Seconal
- Sodium quinalbarbitone
- Somosal
- Synate
- Trisomnin
Meballymalum Brand Names Mixture
- No information avaliable
Meballymalum Chemical_Formula
C12H18N2O3
Meballymalum RX_link
No information avaliable
Meballymalum fda sheet
Meballymalum msds (material safety sheet)
Meballymalum Synthesis Reference
No information avaliable
Meballymalum Molecular Weight
238.283 g/mol
Meballymalum Melting Point
100 oC
Meballymalum H2O Solubility
550 mg/L
Meballymalum State
Solid
Meballymalum LogP
1.879
Meballymalum Dosage Forms
Capsule
Meballymalum Indication
For the Short-term treatment of intractable insomnia for patients habituated to barbiturates
Meballymalum Pharmacology
Secobarbital, a barbiturate, is used for the induction of anesthesia prior to the use of other general anesthetic agents and for induction of anesthesia for short surgical, diagnostic, or therapeutic procedures associated with minimal painful stimuli. Little analgesia is conferred by barbiturates; their use in the presence of pain may result in excitation.
Meballymalum Absorption
No information avaliable
Meballymalum side effects and Toxicity
No information avaliable
Meballymalum Patient Information
No information avaliable
Meballymalum Organisms Affected
Humans and other mammals
